Potential new drug target may protect against certain neurodegenerative diseases
Penn Medicine researchers have discovered that hypermethylation - the epigenetic ability to turn down or turn off a bad gene implicated in 10 to 30 percent of patients with Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal ...
Mar 20, 2015
0
87